Immunome IMNM
NASDAQ IMNM
$20.89 -0.62 (-2.88%)
As of: Oct 1, 2026 · 3:59 PM EDT

Immunome (IMNM) EV to FCF (2023)

Updated

Immunome's (IMNM) EV to FCF was 4.24 for Q3 2023, down 72.8% from the prior quarter.

Analysis

Immunome (IMNM) EV to FCF (2023) Analysis & Trends

Over the twelve months ended Sep 30, 2023, Immunome's EV to FCF came in at -34.63.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Immunome 2.44 Bn 410.39 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 4.24
Jun 30, 2023 15.56
Mar 31, 2023 10.87
API Access

Immunome EV to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=IMNM&period=max&api_key=YOUR_API_KEY